Comecer will attend the 27^th EAHP Congress

Comecer will attend the 27^th Congress of the EAHP, the European Association of Hospital Pharmacists in Lisbon, Portugal, from March 22 to 24.

Visit us at booth #15 to see the PHARMODUCT – Automatic compounding system, an innovative automatic system for antineoplastic compounding, increasing the efficiency of the oncology drug dispensing process.

Pharmoduct guides pharmacists, step-by-step, on the methods, quantity, and production times through an enhanced and controlled process that leverages smart automation; it is a good device for the preparation of personalized chemotherapy doses.

This system is able to reconstitute, transfer and dilute oncology drugs in order to prepare final dose and multi-dose bags. The system can manage more than 300 different drugs. The introduction of Pharmoduct in the Compounding Lab will improve the entire chemotherapy preparation workflow.

What is compounding?

The term "compounding" refers to the creation of a customised, patient-specific drug formulation based on a specific medical prescription: the ingredients indicated by the doctor are mixed in the right proportions to meet patient’s needs. 
Pharmaceutical compounding formulations can be prepared directly by hospital pharmacists or in pharmacies specialising in compounding. Such preparations are mostly intended for parenteral infusion or oral administration, and are often required for chemotherapy treatment in oncology, parenteral nutrition, antibiotic administration, etc.

What are the benefits of Compounding?

There are benefits associated with compounding, many of which focus on providing patients with pharmaceutical products that have been customized to fit their own unique needs when standard marketed drugs fail to do so.
Compounding is the creation of a personalized drug to meet the unique needs of a patient. It is performed by a licensed pharmacist, a licensed physician or a person under the supervision of a licensed pharmacist. In Hospitals and Compounding Labs worldwide, an enormous number of oncology treatments are prepared every day.

What are the advantages of using automation in compounding?

• High performance
• Top accuracy
• Patient safety
• Full traceability
• Operator protection
• Total flexibility

What are the advantages of Pharmoduct vs traditional automation?

Existing robotic compounding systems only replicate manual operations without any real optimization of the whole compounding process: therapies are prepared one after the other in the order of prescription. The main consequence of this is the fact that pharmacies still have a very low control of drug waste and related costs.

High performance: Pharmoduct is an automated and patented device for the sterile preparation of personalised oncology drugs, which optimizes workflows reading the electronic prescriptions and grouping the ones that are based on the same API in a comprehensive macro-dose. 
Patient safety & Operator protection: Pharmoduct is a device capable of automatically preparing the final dose for the patient without any direct manipulation by the operator.
Top accuracy: Pharmoduct, thanks to a gravimetric accurate measuring system, is able to check the correct dosage of each preparation in real time.
Significant savings: Pharmoduct streamlines the process by reducing working remains with next to zero waste. The operating characteristic allows the complete exploitation of overfill quantity in the vials, with a consequent economic enhancement guaranteed.

Schedule your Pharmoduct product demo at the booth